uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted May 24, 2013

Maker of Neuropathic Pain Product Warned For Drug Claims, Misbranding

On April 11, 2013, the FDA issued a warning letter to Realm Labs, LLC, following a review of the company’s websites which found statements made about its NeuRemedy products to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at